Metropolis Healthcare Q3 net falls 30% at Rs 41 cr
Revenues, however, increased to Rs 293.1 crore in the period under review as against Rs 274.7 crore in the same period of 2020-21 fiscal
Stay updated with breaking news from Hitech Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revenues, however, increased to Rs 293.1 crore in the period under review as against Rs 274.7 crore in the same period of 2020-21 fiscal
Mumbai (Maharashtra) [India], April 19 (ANI/NewsVoir): Roche Diagnostics India launched its Quantitative antibody test- Elecsys Anti SARS CoV-2 S in January this year. The test since then has now been widely used in government and private hospitals and labs in various parts across the country. Roche Elecsys Anti SARS CoV-2 S test measures antibodies that could help detect a past natural infection or body's immune response to the vaccine. Roche Elecsys SARS CoV-2 S quantitative antibody test detects and quantifies antibodies in serum or plasma against the spike protein present on the surface o...
Metropolis Healthcare - Acquires Hitech Diagnostics in South India - ICICI Securities